EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparative Risk of Acute Anemia and Urinary Tract Infection With Sulfamethoxazole-Trimethoprim Versus Dapsone After Kidney Transplant

Artemis R Huntsman iD, Christian J Squires iD, Joy Dray Vongspanich, Jeremiah J Duby iD

Annals of Pharmacotherapy · 2026

DOI: 10.1177/10600280251367427 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Annals of Pharmacotherapy, 2026. Verfasst von Artemis R Huntsman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Solid Organ Transplant Specialty Pharmacy, University of California Davis Medical Center, Sacramento, CA, USA. Hauptthemen laut MEDLINE: Dapsone, Kidney Transplantation, Urinary Tract Infections, Trimethoprim, Sulfamethoxazole Drug Combination. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dapsone is an alternative prophylactic agent for opportunistic infection in kidney transplant recipients (KTRs) with sufficient glucose-6-phosphate dehydrogenase levels. Potential disadvantages include increased risk for anemia and urinary tract infection (UTI) with dapsone.

Objective

The objective of this study was to compare the risks of anemia and UTI in KTRs who received prophylaxis for opportunistic infection after renal transplant with dapsone versus sulfamethoxazole-trimethoprim (SMX-TMP).

Methods

This single-center, retrospective, cohort review was conducted at a large academic health system. Adult patients who received SMX-TMP or dapsone prophylaxis after renal transplant were included. The primary outcome was risk of acute anemia within 90 days of transplant. Secondary outcomes included the risk of UTI post-transplant. Log-rank test was used for time-to-event analysis for the primary outcome.

Results

A total of 153 patients were included in the analysis. Patients were more likely to experience acute anemia while on dapsone compared with SMX-TMP (hazard ratio = 2.13, 95% confidence interval = 1.04-4.38, P = 0.04). No differences were observed in the rates of blood transfusion (14.5% vs 18.4%, P = 0.52) or use of erythropoiesis-stimulating agents (40.2% vs 48.7%, P = 0.331) between SMX-TMP and dapsone groups, respectively. The prevalence of UTI was comparable between groups (23.4% vs 23.7%, P > 0.999). Conclusion and Relevance: The risk of anemia was twofold higher in KTRs who received dapsone compared with SMX-TMP but did not appear to affect the rates of erythropoiesis-stimulating agent use or blood transfusion. There was no difference in the risk of UTI. These findings may inform agent selection and monitoring of prophylaxis for opportunistic infection in KTRs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DapsoneKidney TransplantationUrinary Tract InfectionsTrimethoprim, Sulfamethoxazole Drug CombinationAnemiaHumansFemaleRetrospective StudiesMaleMiddle AgedAdultOpportunistic Infections

Stichwörter der Autor:innen

SMX-TMPUTIanemiadapsonekidney transplant

Substanzen

DapsoneTrimethoprim, Sulfamethoxazole Drug Combination

Autor:innen und Institutionen

  • Solid Organ Transplant Specialty Pharmacy, University of California Davis Medical Center, Sacramento, CA, USA.
  • Primary Care, University of California Davis Medical Center, Sacramento, CA, USA.
  • Infectious Disease and Solid Organ Transplant, University of California Davis Medical Center, Sacramento, CA, USA.
  • Research and Outcomes, University of California Davis Medical Center, Sacramento, CA, USA.
  • University of California San Francisco School of Pharmacy, Sacramento, CA, USA.

ORCID-Profile: Artemis R Huntsman, Christian J Squires, Jeremiah J Duby

Zitieren

APA

Huntsman, A. R., Squires, C. J., Dray Vongspanich, J., & Duby, J. J. (2026). Comparative Risk of Acute Anemia and Urinary Tract Infection With Sulfamethoxazole-Trimethoprim Versus Dapsone After Kidney Transplant. Annals of Pharmacotherapy. https://doi.org/10.1177/10600280251367427

Vancouver

Huntsman AR, Squires CJ, Dray Vongspanich J, Duby JJ. Comparative Risk of Acute Anemia and Urinary Tract Infection With Sulfamethoxazole-Trimethoprim Versus Dapsone After Kidney Transplant. Annals of Pharmacotherapy. 2026. doi:10.1177/10600280251367427

BibTeX
@article{Huntsman2026,
  author = {Huntsman, Artemis R and Squires, Christian J and Dray Vongspanich, Joy and Duby, Jeremiah J},
  title = {Comparative Risk of Acute Anemia and Urinary Tract Infection With Sulfamethoxazole-Trimethoprim Versus Dapsone After Kidney Transplant},
  journal = {Annals of Pharmacotherapy},
  year = {2026},
  doi = {10.1177/10600280251367427}
}
Kostenlos starten →